We work with academic groups, biotech companies, pharmaceutical leaders, and institutions worldwide, building long-lasting relationships that generate impact and innovation.
Years experience
0
Years experience
0
Years experience
0
Case studies
Learn More About Our Success Stories
We participated in the development of a new chemical entity licensed to Novartis, now in Phase III clinical trials as a novel cancer immunotherapy.
In a Joint Research Unit with Laboratorios ESTEVE, we developed a new chemical entity for neuropathic pain that reached Phase III, and was later repurposed for COVID-19 with positive proof-of-concept results.
Learn More About Our Success Stories
Oluptiur? Equi sumquis tempore pratur res est et ut eum estiunt ibusci non restem volorun diaecae. Ita vitis enis il mintis cones dolenda non nis.
Lorem ipsum
Us. Lo endae ide explaccum quaspereici quature simillo